探索

下載客戶端
SAGE Cardiology and Cardiovascular Medicine

SCVA March 2016 Podcast: Cardiopulmonary Bypass Without Heparin

22min2016 APR 13
播放聲音
喜歡
評論
分享

詳細信息

Due to familiarity, short half-life, ease of monitoring, and the availability of a reversal agent, heparin remains the anticoagulant of choice for cardiac operations requiring cardiopulmonary bypass (CPB). However, occasionally patients require CPB but should not receive heparin, most often because of acute or subacute heparin-induced thrombocytopenia (HIT). In these cases, if it is not feasible to wait for the disappearance of HIT antibodies, an alternative anticoagulant must be selected. A number of non-heparin anticoagulant options have been explored. However, current recommendations suggest the use of a direct thrombin inhibitor such as bivalirudin. This review describes the use of heparin alternatives for the conduct of CPB with a focus on the direct thrombin inhibitors. To view the article, click here.

查看更多

SCVA COVID-19 Podcast Part 2

19min

SCVA COVID-19 Podcast Part 1

23min

SCVA March 2020 Podcast: A Retrospective Analysis of the Use of 3-Factor Prothrombin Complex Concentrates for Refractory Bleeding After Cardiopulmonary Bypass in Children Undergoing Heart Surgery: A Matched Case-Control Study

9min

SCVA July 2019 Podcast: Congenital Cardiac Anesthesia Society Meeting Abstracts

12min

SCVA June 2019 Podcast: Noteworthy Literature in 2018 for Cardiovascular Anesthesiologists and Intensivists

14min

SCVA April 2018 Podcast: Society for the Advancement of Transplant Anesthesia: Liver Transplant Anesthesia Fellowship—White Paper Advocating Measurable Proficiency in Transplant Specialties Training

13min

SCVA June 2017 Podcast: Occupational Radiation Exposure of Anesthesia Providers

12min

SCVA March 2017 Podcast: Noteworthy Literature Published in 2016 for Abdominal Organ Transplantation Anesthesiologists: Liver

20min